Systemic antifungal drug use in Belgium—One of the biggest antifungal consumers in Europe
Background: Reports on the consumption of systemic antifungal drugs on a national level are scarce although of high interest to compare trends and the associated epidemiology in other countries and to assess the need for antifungal stewardship programmes. Objectives: To estimate patterns of Belgian inpatient and outpatient antifungal use and provide reference data for other countries. Methods: Consumption records of antifungals were collected in Belgian hospitals between 2003 and 2016. Primary healthcare data were available for the azoles for the period 2010-2016. Results: The majority of the... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Schlagwörter: | Pathologie maladies infectieuses / Dermatologie / antifungal agents / hospital / prescription rates / primary care / public health / surveillance |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26600688 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287309 |